摘要
目的 分析重症心肌炎合并呼吸衰竭 ECMO 联合 CRRT 治疗用综合护理的价值。方法 对 2021 年 9
月-2023 年 8 月本科接诊重症心肌炎合并呼吸衰竭病人（n=68）进行随机分组。试验和对照组各 34 人，前者 ECMO
和 CRRT 治疗期间采取综合护理，后者行常规护理。对比并发症等指标。结果 关于护理质量：试验组数据达到
了（98.53±1.01）分，而对照组数据则仅有（89.34±1.95）分，相比较下，试验组的护理质量更好（P＜0.05）。
并发症：试验组发生率低至 2.94%，而对照组数据则达到了 20.59%，相比较下，试验组的发生率更低（P＜0.05）。
关于总有效率和满意度：试验组数据比对照组高（P＜0.05）。左室射血分数和心输出量：干预结束时，试验组
数据比对照组高（P＜0.05）。结论 重症心肌炎合并呼吸衰竭 ECMO 和 CTTR 治疗期间用综合护理，病人的护
理质量更好，并发症发生率更低，满意度更高，护理效果提升更加明显，心功能改善更为迅速。
关键词： 呼吸衰竭；综合护理；重症心肌炎；ECMO
Abstract
Objective To analyze the value of ECMO combined with CRRT in the treatment of severe myocarditis
complicated with respiratory failure. Methods The patients (n=68) with severe myocarditis combined with respiratory
failure were randomly assigned from September 2021 to August 2023. There were 34 patients in the experiment and 34
patients in the control group, the former received comprehensive nursing during ECMO and CRRT treatment, and the
latter received routine nursing. Complications and other indicators were compared. Results Regarding the quality of
nursing care, the experimental group achieved (98.53±1.01) points, while the control group only achieved (89.34±1.95)
points. Compared with the experimental group, the quality of nursing care was better (P<0.05). Complications: The
incidence of the experimental group was as low as 2.94%, while that of the control group was 20.59%, and the incidence
of the experimental group was lower than that of the control group (P<0.05). The total response rate and satisfaction rate
of the experimental group were higher than those of the control group (P<0.05). Left ventricular ejection fraction and
cardiac output: At the end of intervention, the data in experimental group were higher than that in control group (P<0.05).
Conclusion With comprehensive nursing during ECMO and CTTR treatment of severe myocarditis combined with
respiratory failure, the quality of nursing is better, the incidence of complications is lower, the satisfaction is higher, the
nursing effect is more obvious, and the cardiac function is improved more rapidly.
Key words： Respiratory failure; Comprehensive nursing; Severe myocarditis; ECMO
参考文献 References
[1] 顾翠生, 徐慧, 孙小燕. 综合护理在 ECMO 联合 CRRT对重症心肌炎合并呼吸衰竭患者的应用效果[J]. 中西医结合护理（中英文）,2022,8（1）:127-129.
[2] 李莹. ECMO 联合 CRRT 治疗重症心肌炎合并呼衰中综合护理的应用价值研究[J]. 健康必读,2020（12）:101.
[3] 李慧,闫蕾. ECMO+iABP 联合护理模式在紧急抢救重症心肌炎患者中的作用[J]. 世界最新医学信息文摘（连续型电子期刊）,2020,20（1）:265.
[4] 刘晓鸿,陈晓霞,于兰,等. 体外膜肺氧合（ECMO）与多学科协作在急性暴发性心肌炎患者中的应用[J]. 临床医学进展,2021,11（10）:4732-4737.
[5] VEIZADES, STEFAN, TSO, ALEXANDRIA, NGUYEN,PATRICIA K.. Infection, inflammation and thrombosis: areview of potential mechanisms mediating arterial thrombosisassociated with influenza and severe acute respiratory syndromecoronavirus 2[J]. Biological chemistry,2022,403（2）:231-241.
[6] 张祖惠,崔慧. 重症心肌炎合并房室传导阻滞患者应用多元化知识宣讲联合知信行干预的护理效果评估[J].贵州医药,2022,46（9）:1496-1497.
[7] 王丽. 基于持续质量改进的医护一体化护理在重症心肌炎伴房室传导阻滞患者中的护理效果观察[J]. 江西医药,2022,57（12）:2206-2208.
[8] FADI NASR, ELIE EL RASSY, GEORGINA MAALOUF, etal. Severe ophthalmoplegia and myocarditis following theadministration of pembrolizumab[J]. European journal ofcancer: official journal for European Organization for Researchand Treatment of Cancer （ EORTC ） [and] EuropeanAssociation for Cancer Research （EACR）,2019,91171-173.
[9] 姚磊. ECMO 联合 CRRT 治疗重症心肌炎合并呼衰中综合 护 理 的 应 用 价 值 研 究 [J]. 养 生 保 健 指 南 ,2019（18）:141.
[10] 吴莉萍,覃振梅. ECMO 联合 CRRT 综合护理在重症心肌炎合并呼吸衰竭患者中的应用效果[J]. 临床护理研究,2023,32（15）:146-148.